Gen-Probe has obtained expanded FDA clearance to use its Procleix Ultrio assay in screening donated blood for the hepatitis B virus. The agency previously approved the assay for use in examining donated blood for HIV-1 and the hepatitis C virus. Gen-Probe said the expanded approval will allow it to receive a milestone payment of $10 million from Chiron.

Related Summaries